- Home
- REFR vs SRTS Comparison
REFR vs SRTS Comparison
Compare REFR & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REFR
- SRTS
- Stock Information
- Founded
- REFR 1965
- SRTS 2010
- Country
- REFR United States
- SRTS United States
- Employees
- REFR N/A
- SRTS N/A
- Industry
- REFR Multi-Sector Companies
- SRTS Medical/Dental Instruments
- Sector
- REFR Miscellaneous
- SRTS Health Care
- Exchange
- REFR Nasdaq
- SRTS Nasdaq
- Market Cap
- REFR 51.8M
- SRTS 51.8M
- IPO Year
- REFR N/A
- SRTS 2016
- Fundamental
- Price
- REFR $1.79
- SRTS $3.25
- Analyst Decision
- REFR
- SRTS Strong Buy
- Analyst Count
- REFR 0
- SRTS 3
- Target Price
- REFR N/A
- SRTS $8.00
- AVG Volume (30 Days)
- REFR 56.4K
- SRTS 90.3K
- Earning Date
- REFR 11-06-2025
- SRTS 11-13-2025
- Dividend Yield
- REFR N/A
- SRTS N/A
- EPS Growth
- REFR N/A
- SRTS N/A
- EPS
- REFR N/A
- SRTS N/A
- Revenue
- REFR $1,222,239.00
- SRTS $37,564,000.00
- Revenue This Year
- REFR N/A
- SRTS N/A
- Revenue Next Year
- REFR N/A
- SRTS $47.33
- P/E Ratio
- REFR N/A
- SRTS N/A
- Revenue Growth
- REFR N/A
- SRTS 3.29
- 52 Week Low
- REFR $0.93
- SRTS $3.03
- 52 Week High
- REFR $2.31
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- REFR 61.80
- SRTS 45.67
- Support Level
- REFR $1.40
- SRTS $3.11
- Resistance Level
- REFR $1.94
- SRTS $3.68
- Average True Range (ATR)
- REFR 0.17
- SRTS 0.14
- MACD
- REFR 0.04
- SRTS 0.04
- Stochastic Oscillator
- REFR 66.67
- SRTS 35.32
About REFR Research Frontiers Incorporated
Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.